Adalimumab in CD
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy
Fibrin glue in perianal CD
Diet intervention study in CD:IgG antibodies against food antigens
Metronidazol ointment 10% in perianal CD
Certolizumab in CD
Reinduction with certolizumab in CD
Infliximab, azathioprine or combo in CD
5ASA vs AZA in CD postop recurrence
The inflammatory bowel diseases and ambient air pollution: a novel association